Your session is about to expire
← Back to Search
Traditional Chinese Medicine
Acupuncture for Cancer Pain
N/A
Waitlist Available
Led By Ronald M Glick, MD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline visit
Awards & highlights
Study Summary
This trial is testing whether acupuncture can help relieve pain for people with advanced cancer.
Eligible Conditions
- Cancer
- Cancer Pain
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week 4 and weeks 9, 10, 11, 12
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 4 and weeks 9, 10, 11, 12
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Assessing for treatment-related adverse events as recorded by Acupuncture Safety Record
Assessing for treatment-related and illness-related symptoms as recorded by Symptoms Checklist (SC)
Measuring effectiveness of acupuncture by assessing change in anxiety symptom ratings Weekly from Week 1-Week 12 and 4 week follow-up using PROMIS ® Item Bank v.1.0 measures: Emotional Distress-Anxiety - Short Form 4a
+11 moreSide effects data
From 2013 Phase 1 & 2 trial • 104 Patients • NCT013058112%
Serious unexpected
2%
Pain on needling
100%
80%
60%
40%
20%
0%
Study treatment Arm
Bi-Weekly Acupuncture
Wait List
Trial Design
1Treatment groups
Experimental Treatment
Group I: AcupunctureExperimental Treatment1 Intervention
Eligible participants:
have advanced stage cancer and associated pain
will receive up to 12 acupuncture sessions
will attend sessions at UPMC's Center for Integrative Medicine
will complete study assessments at each visit
will complete a follow-up 4 to 6 weeks after their last acupuncture visit. Total study involvement will range from 16 to 18 weeks.
Find a Location
Who is running the clinical trial?
University of PittsburghLead Sponsor
1,720 Previous Clinical Trials
16,342,805 Total Patients Enrolled
Ronald M Glick, MDPrincipal InvestigatorHillman Cancer Center
2 Previous Clinical Trials
123 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have had acupuncture in the last 3 months.You are experiencing moderate to severe pain, rated 4/10 or higher on a pain scale.You are taking blood thinners, except for preventive doses of heparin or low molecular weight heparin, or anti-platelet medications.Your disease has spread to other parts of your body and is causing pain.
Research Study Groups:
This trial has the following groups:- Group 1: Acupuncture
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many participants are being accepted into this clinical study?
"Affirmative. Clinicaltrials.gov contains details which demonstrate that this clinical trial is open to recruitment, having first been posted on July 5th 2022 and edited lastly on the same day. A total of 60 patients across one location are being admitted for participation in the study."
Answered by AI
Is enrollment now open for this research endeavor?
"Current information available on clinicaltrials.gov suggests that this medical trial is in the process of enrolling patients. The first listing was published as recently as July 5th, 2022 and has since been updated for accuracy."
Answered by AI
Share this study with friends
Copy Link
Messenger